Disclosures for "Improvement in Patient-Reported Outcomes When Ubrogepant Is Administered During the Migraine Prodrome (Premonitory Phase): Results From the PRODROME Trial")
-
Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has stock in Biohaven. Dr. Lipton has stock in Manistee. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from NINDS. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from NIA. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from NIA. The institution of Dr. Lipton has received research support from NIH. The institution of Dr. Lipton has received research support from Veterans Administration. The institution of Dr. Lipton has received research support from NIH. Dr. Lipton has received publishing royalties from a publication relating to health care.
-
Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to AAN interests or activities.
-
Dr. Ma has received personal compensation for serving as an employee of AbbVie. Dr. Ma has received stock or an ownership interest from AbbVie.
-
Dr. Smith has received personal compensation for serving as an employee of AbbVie. Dr. Smith has stock in AbbVie. Dr. Smith has received publishing royalties from a publication relating to health care.
-
Lawrence Severt has nothing to disclose.
-
Jonathan Stokes has received personal compensation for serving as an employee of AbbVie. Jonathan Stokes has received stock or an ownership interest from AbbVie.
-
Pranav Gandhi has received personal compensation for serving as an employee of AbbVie. Pranav Gandhi has stock in AbbVie Inc.
-
Dr. Jariwala-Parikh has received personal compensation for serving as an employee of AbbVie. Dr. Jariwala-Parikh has stock in AbbVie.
-
Dr. Trugman has received personal compensation for serving as an employee of AbbVie. Dr. Trugman has stock in AbbVie.
-
Dr. Dodick has received personal compensation for serving as an employee of Mayo Clinic. Dr. Dodick has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Amgen. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AEON. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cerecin. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Eli Lilly. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Theranica. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for WL Gore. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pieris. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Revance. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Equinox . Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cooltech. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CtrlM. An immediate family member of Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Nocira. An immediate family member of Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GSK. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as a Consultant for Ayya Biosciences. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma. Dr. Dodick has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Atria. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cooltech. Dr. Dodick has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for All companies listed as consultant also apply to advisory board. . Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Epien. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for KingDevick Technologies. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Precon Health. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Ontologics. Dr. Dodick has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Matterhorn. Dr. Dodick has received stock or an ownership interest from Healint. Dr. Dodick has received stock or an ownership interest from Theranica. Dr. Dodick has received stock or an ownership interest from Aural Analytics . Dr. Dodick has received stock or an ownership interest from Epien. Dr. Dodick has received stock or an ownership interest from Matterhorn. Dr. Dodick has received stock or an ownership interest from Ontologics. Dr. Dodick has received stock or an ownership interest from Precon Health. Dr. Dodick has received stock or an ownership interest from King Devick Technologies. Dr. Dodick has received stock or an ownership interest from Nocira. Dr. Dodick has received stock or an ownership interest from Exsano. Dr. Dodick has received stock or an ownership interest from Palion. Dr. Dodick has received stock or an ownership interest from Second opinion/mobile health. Dr. Dodick has received stock or an ownership interest from AYYA Biosciences. Dr. Dodick has received stock or an ownership interest from Perfood. The institution of Dr. Dodick has received research support from Department of Defense. The institution of Dr. Dodick has received research support from American Migraine Foundation. The institution of Dr. Dodick has received research support from Patient Centered Outcomes Research Institute. The institution of Dr. Dodick has received research support from Henry Jackson Foundation. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received intellectual property interests from a discovery or technology relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received publishing royalties from a publication relating to health care. Dr. Dodick has received personal compensation in the range of $5,000-$9,999 for serving as a CME symposia with CME Outfitters. Dr. Dodick has received personal compensation in the range of $10,000-$49,999 for serving as a CME symposia speaker with WebMD/Medscape. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consulting with KLJ Associates. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consulting with Curry Rockefeller Group. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consulting with DeepBench. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a CME symposia speaker with Medlogix Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a CME symposia speaker with Miller Medical Communications. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a speaker at annual meeting with Southern Headache Society. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a consulting with Majallin LLC. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a Consulting/Advisory board with Satsuma. Dr. Dodick has received personal compensation in the range of $500-$4,999 for serving as a CME symposia speakers with Global Access Meetings. Dr. Dodick has a non-compensated relationship as a Chair with American Brain Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Committee member/Course Director with American Academy of Neurology that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair/Immediate Past Chair with American Migraine Foundation that is relevant to AAN interests or activities. Dr. Dodick has a non-compensated relationship as a Chair Global Patient Advocacy Coalition with International Headache Society that is relevant to AAN interests or activities.